Target validation assay

Details for Australian Patent Application No. 2006203974 (hide)

Owner AVEO Pharmaceuticals, Inc.

Inventors Gyuris, Jeno; Clark, Steven C.; Weng, Zhigang

Agent Cullen & Co

Pub. Number AU-A-2006203974

PCT Pub. Number WO2006/074292

Priority 60/642,243 06.01.05 US

Filing date 6 January 2006

Wipo publication date 13 July 2006

International Classifications

A01K 67/00 (2006.01) Rearing or breeding animals, not otherwise provided for

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/074292 Priority application(s): WO2006/074292

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203978-Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia

2006203970-Polypeptides having nucleic acid binding activity